AdvisorShares Investments’s Halozyme HALO Stock Holding History

AdvisorShares Investments’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,677	Closed	-$949K	–	306
2022 Q4	$949K	Buy	+16,677	New	+$854K	0.27%	55
2022 Q3	–	Sell	-19,472	Closed	-$857K	–	327
2022 Q2	$857K	Buy	+19,472	New	+$842K	0.24%	46

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

AdvisorShares Investments's HALO Position: Q1 2023 in Review

AdvisorShares Investments sold out of Halozyme (HALO) in Q1 2023, closing a stake of 16,677 shares — an estimated $949K sold.

AdvisorShares Investments first reported a position in HALO in Q2 2022 and held it in 2 quarters. The position peaked at $949K in Q4 2022. 386 funds tracked by Wall St. Rank hold HALO as of Q1 2023.

AdvisorShares Investments reported no remaining Halozyme position as of Q1 2023 after selling out during the quarter.
AdvisorShares Investments sold 16,677 Halozyme shares in Q1 2023, an estimated $949K.
AdvisorShares Investments first reported a position in Halozyme in Q2 2022 and held it in 2 quarters.
AdvisorShares Investments's Halozyme position peaked at $949K in Q4 2022.
386 funds tracked by Wall St. Rank held Halozyme as of Q1 2023.

Based on AdvisorShares Investments's 13F filing for Q1 2023, filed 9 May 2023.